Since the beginning of 2025, Swiss start-ups have been able to apply for funding under the EIC Accelerator Programme again after a four-year hiatus. Neutrality, Verity, Pregnolia and DePoly have now ...

Schlieren-based Polaroid Therapeutics has received CE marking for its first product, POLTX_Fiber, a Class IIb antimicrobial gelling fiber dressing. The company is preparing to introduce the wound ...

Hamilton Medical has successfully completed the acquisition of STIMIT AG, based in Biel. The integration of STIMIT AG into ...

Two other Tech Seed loans worth CHF 100,000 each were granted to Bioneris for its food bacteria detection device and to Divea for its filters that capture carbon at source.

The financing will enable Geneva-based Clee Medical to accelerate the development and clinical validation of its Neuro Access platform, a minimally invasive technology designed to help neurosurgeons ...

ENGIE, through its ENGIE New Ventures investment fund for startups that accelerate the energy transition, announces a ...

Basel-based biotech group Swiss Rockets has acquired U.S. life sciences company Complete Genomics. The acquisition will strengthen Swiss Rockets’ portfolio, adding sequencing capabilities to support ...

At the same time, the average age of liquidated startups increased. From 2016 till 2022 the average age fluctuated around 6.4 years. From 2022 the average age started to rise continuously until it ...

Three Geneva-based digital projects have each been awarded CHF 50,000: fintech startup Scenario X and ICT startups Flottando and Axy. In addition, an impact-driven life sciences project, Nose ...

DIC Corporation, a globally leading fine chemicals company, is launching a USD 62 million investment platform to back startups developing Physical AI technologies. DIC plans to establish a startup ...

For Albatross, Wallapop represents a demanding real-world environment for AI discovery. With a constantly evolving catalog of one-of-a-kind items and high listing velocity, Wallapop provides an ideal ...

FimmCyte has announced a strategic research collaboration and option-to-license agreement with Gedeon Richter Plc., a leading pharmaceutical company in women’s health. Ritcher operates Central ...